Applications of proteomics in ovarian cancer: dawn of a new era
A Ghose, SVN Gullapalli, N Chohan, A Bolina… - Proteomes, 2022 - mdpi.com
The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The
patients present an advanced stage at diagnosis. This heterogeneous disease has …
patients present an advanced stage at diagnosis. This heterogeneous disease has …
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
Y Xiao, M Bi, H Guo, M Li - EBioMedicine, 2022 - thelancet.com
Ovarian cancer (OC) is a heterogeneous disease with the highest mortality rate and the
poorest prognosis among gynecological malignancies. Because of the absence of specific …
poorest prognosis among gynecological malignancies. Because of the absence of specific …
Circulating microRNAs: Biomarkers of disease
Y Wu, Q Li, R Zhang, X Dai, W Chen, D Xing - Clinica Chimica Acta, 2021 - Elsevier
MicroRNAs are a class of endogenous noncoding single-stranded RNA molecules with
approximately 20–24 nucleotides and are associated with a broad range of biological …
approximately 20–24 nucleotides and are associated with a broad range of biological …
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer
Background Circulating miRNAs are known to play important roles in intercellular
communication. However, the effects of exosomal miRNAs on cells are not fully understood …
communication. However, the effects of exosomal miRNAs on cells are not fully understood …
[HTML][HTML] Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer
Ovarian cancer is mostly diagnosed at advantaged stages due to the lack of early diagnostic
biomarkers. The common metastasis pattern is characterized by peritoneal dissemination …
biomarkers. The common metastasis pattern is characterized by peritoneal dissemination …
Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes
L Giannopoulou, M Zavridou, S Kasimir-Bauer… - Translational …, 2019 - Elsevier
Ovarian cancer still remains the most lethal female cancer, since in most cases it is
diagnosed at an advanced stage. Usually after completion of primary treatment …
diagnosed at an advanced stage. Usually after completion of primary treatment …
Circulating cell-free microRNAs as clinical cancer biomarkers
V Armand-Labit, A Pradines - Biomolecular concepts, 2017 - degruyter.com
MicroRNAs (miRNAs) are non-coding small RNAs that are master regulators of genic
expression and consequently of many cellular processes. But their expression is often …
expression and consequently of many cellular processes. But their expression is often …
Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer
Recent studies posit a role for non-coding RNAs in epithelial ovarian cancer (EOC).
Combining small RNA sequencing from 179 human serum samples with a neural network …
Combining small RNA sequencing from 179 human serum samples with a neural network …
Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer
Y Shi, Z Wang, X Zhu, L Chen, Y Ma, J Wang… - International journal of …, 2020 - Springer
Background Gastric cancer (GC) patients are usually diagnosed in advanced stages which
results in high mortality. This study aimed to identify novel circulating miRNAs as biomarkers …
results in high mortality. This study aimed to identify novel circulating miRNAs as biomarkers …
A review on the role of miR-1246 in the pathoetiology of different cancers
S Ghafouri-Fard, T Khoshbakht, BM Hussen… - Frontiers in molecular …, 2022 - frontiersin.org
miR-1246 is a microRNA firstly recognized through application of a high throughput
sequencing technique in human embryonic stem cells. Subsequent studies have shown the …
sequencing technique in human embryonic stem cells. Subsequent studies have shown the …